- Home
- CLW vs ARCT Comparison
CLW vs ARCT Comparison
Compare CLW & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLW
- ARCT
- Stock Information
- Founded
- CLW 2005
- ARCT 2013
- Country
- CLW United States
- ARCT United States
- Employees
- CLW N/A
- ARCT N/A
- Industry
- CLW Paper
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CLW Basic Materials
- ARCT Health Care
- Exchange
- CLW Nasdaq
- ARCT Nasdaq
- Market Cap
- CLW 481.8M
- ARCT 444.5M
- IPO Year
- CLW N/A
- ARCT N/A
- Fundamental
- Price
- CLW $27.30
- ARCT $17.77
- Analyst Decision
- CLW Buy
- ARCT Strong Buy
- Analyst Count
- CLW 1
- ARCT 7
- Target Price
- CLW $37.00
- ARCT $63.60
- AVG Volume (30 Days)
- CLW 301.0K
- ARCT 439.9K
- Earning Date
- CLW 02-13-2025
- ARCT 03-06-2025
- Dividend Yield
- CLW N/A
- ARCT N/A
- EPS Growth
- CLW 85.68
- ARCT N/A
- EPS
- CLW 11.70
- ARCT N/A
- Revenue
- CLW $1,383,600,000.00
- ARCT $160,399,000.00
- Revenue This Year
- CLW $14.27
- ARCT $6.54
- Revenue Next Year
- CLW N/A
- ARCT $0.25
- P/E Ratio
- CLW $2.30
- ARCT N/A
- Revenue Growth
- CLW N/A
- ARCT N/A
- 52 Week Low
- CLW $23.97
- ARCT $14.30
- 52 Week High
- CLW $57.13
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- CLW 39.33
- ARCT 54.71
- Support Level
- CLW $25.38
- ARCT $16.54
- Resistance Level
- CLW $32.55
- ARCT $19.25
- Average True Range (ATR)
- CLW 1.19
- ARCT 1.19
- MACD
- CLW -0.44
- ARCT 0.14
- Stochastic Oscillator
- CLW 26.78
- ARCT 62.15
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and selling of private label tissue, paperboard, and pulp-based products. The company has two reportable segments namely the consumer products segment which manufactures and sells a complete line of at-home tissue products as well as AFH products. The pulp and paperboard segment manufactures and markets bleached paperboard for the high-end segment of the packaging industry as well as offers services that include custom sheeting, slitting and cutting of paperboard. It generates maximum revenue from Pulp and Paperboard segment. Geographically, it derives maximum revenue from the United States.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.